Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

被引:107
作者
Souza-Tarla, CD
Uzuelli, JA
Machado, AA
Gerlach, RF
Tanus-Santos, JE
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Med, Ribeirao Preto, Brazil
[3] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol, BR-14049 Ribeirao Preto, Brazil
基金
巴西圣保罗研究基金会;
关键词
metalloproteinases; methods; zymography;
D O I
10.1016/j.clinbiochem.2005.02.010
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To examine whether a linear relationship exists between the volume of plasma loaded in each gel lane and the gelatinolytic activities of plasma matrix metal loproteinase (pMMP)-2 and pMMP-9, and the influences of plasma storage temperature, fasting, and a variable number of repeated freeze-thaw cycles. Design and methods: Plasma from venous blood collected into EDTA tubes was stored for 1 month at -20 degrees C or at -70 degrees C until assayed for gelatin zymography of pMMP-2 and pMMP-9. The effects of food intake, repeated freeze-thaw cycles, and the gelatinolytic activity produced by serial dilutions of plasma were examined. Results: Storage temperature, fasting, and up to five repeated freeze-thaw cycles had no effect on the activities of pMMPs (all P < 0.05). A linear relationship was found with plasma volumes below 0.75 mu L/lane for MMP-2, and from 0.75 mu L/lane to 2 mu L/lane for MMP-9. Conclusions: Different volumes of plasma should be studied when pMMP-2 and pMMP-9 activities are studied. Storage temperature, repeated freeze-thaw cycles, and food intake do not affect the activities of pNIMPs. (c) 2005 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:410 / 414
页数:5
相关论文
共 19 条
[1]   Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure [J].
Altieri, P ;
Brunelli, C ;
Garibaldi, S ;
Nicolino, A ;
Ubaldi, S ;
Spallarossa, P ;
Olivotti, L ;
Rossettin, P ;
Barsotti, A ;
Ghigliotti, G .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (08) :648-656
[2]   Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients [J].
Belleguic, C ;
Corbel, M ;
Germain, N ;
Léna, H ;
Boichot, E ;
Delaval, PH ;
Lagente, V .
CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (02) :217-223
[3]   Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Poirier, O ;
Bickel, C ;
Smieja, M ;
Hafner, G ;
Meyer, J ;
Cambien, F ;
Tiret, L .
CIRCULATION, 2003, 107 (12) :1579-1585
[4]  
Farias E, 2000, INT J CANCER, V89, P389, DOI 10.1002/1097-0215(20000720)89:4<389::AID-IJC12>3.0.CO
[5]  
2-J
[6]   Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins [J].
Jacob, MP ;
Cazaubon, M ;
Scemama, A ;
Prié, D ;
Blanchet, F ;
Guillin, MC ;
Michel, JB .
CIRCULATION, 2002, 106 (05) :535-538
[7]   QUANTITATIVE ZYMOGRAPHY - DETECTION OF PICOGRAM QUANTITIES OF GELATINASES [J].
KLEINER, DE ;
STETLERSTEVENSON, WG .
ANALYTICAL BIOCHEMISTRY, 1994, 218 (02) :325-329
[8]   Zymography: A single-step staining method for quantitation of proteolytic activity on substrate gels [J].
Leber, TM ;
Balkwill, FR .
ANALYTICAL BIOCHEMISTRY, 1997, 249 (01) :24-28
[9]   Novel diagnostic test for acute stroke [J].
Lynch, JR ;
Blessing, R ;
White, WD ;
Grocott, HP ;
Newman, MF ;
Laskowitz, DT .
STROKE, 2004, 35 (01) :57-63
[10]   Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma [J].
Makowski, GS ;
Ramsby, ML .
ANALYTICAL BIOCHEMISTRY, 2003, 322 (02) :283-286